Related Experiment Videos
Molecular cancer genetics in eastern and central Europe
1National Institute of Oncology, Budapest, Hungary.
Disease Markers
|December 14, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sperm concentration, hyaluronic acid-binding capacity, aneuploidy and persistent histones in testicular cancer.
Human reproduction (Oxford, England)·2014
Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Journal of clinical immunology·2013
Determination of ng/mL levetiracetam using ultra-high-performance liquid chromatography-photodiode absorbance.
Journal of chromatographic science·2012
Allele loss of tumour suppressor genes on chromosome 17 in human testicular germ cell tumours.
International journal of oncology·2011
The future of primary paediatric care in Europe: reflections and Report of the EPA/UNEPSA Committee.
Acta paediatrica (Oslo, Norway : 1992)·2009
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
British journal of cancer·2008
Evolutionary study of oncogenes and tumor suppressor genes in breast carcinoma.
Journal of Taibah University Medical Sciences·2026
Constructing an Evidence-Based Validity Rationale for a Multi-component Endpoint in Heterogeneous Populations.
Therapeutic innovation & regulatory science·2026
Genetic endocrine tumors focusing on the thyroid.
Best practice & research. Clinical endocrinology & metabolism·2026
Adjunctive nutraceutical strategies in ulcerative colitis: From molecular pathways to clinical outcomes.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Principles and applications of cross-sectional, case-control and cohort studies in gynecologic oncology: from classical observational designs to target trial emulation.
Best practice & research. Clinical obstetrics & gynaecology·2026
Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.
Cancer investigation·2026